Effects of beta-hydroxybutyrate on cognition in memory-impaired adults
- PMID: 15123336
- DOI: 10.1016/S0197-4580(03)00087-3
Effects of beta-hydroxybutyrate on cognition in memory-impaired adults
Abstract
Glucose is the brain's principal energy substrate. In Alzheimer's disease (AD), there appears to be a pathological decrease in the brain's ability to use glucose. Neurobiological evidence suggests that ketone bodies are an effective alternative energy substrate for the brain. Elevation of plasma ketone body levels through an oral dose of medium chain triglycerides (MCTs) may improve cognitive functioning in older adults with memory disorders. On separate days, 20 subjects with AD or mild cognitive impairment consumed a drink containing emulsified MCTs or placebo. Significant increases in levels of the ketone body beta-hydroxybutyrate (beta-OHB) were observed 90 min after treatment (P=0.007) when cognitive tests were administered. beta-OHB elevations were moderated by apolipoprotein E (APOE) genotype (P=0.036). For 4+ subjects, beta-OHB levels continued to rise between the 90 and 120 min blood draws in the treatment condition, while the beta-OHB levels of 4- subjects held constant (P<0.009). On cognitive testing, MCT treatment facilitated performance on the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-cog) for 4- subjects, but not for 4+ subjects (P=0.04). Higher ketone values were associated with greater improvement in paragraph recall with MCT treatment relative to placebo across all subjects (P=0.02). Additional research is warranted to determine the therapeutic benefits of MCTs for patients with AD and how APOE-4 status may mediate beta-OHB efficacy.
Similar articles
-
Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.Methods Find Exp Clin Pharmacol. 1999 Nov;21(9):633-44. Methods Find Exp Clin Pharmacol. 1999. PMID: 10669911 Clinical Trial.
-
Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype.Neurobiol Aging. 2006 Mar;27(3):451-8. doi: 10.1016/j.neurobiolaging.2005.03.016. Epub 2005 Jun 16. Neurobiol Aging. 2006. PMID: 15964100 Clinical Trial.
-
Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.J Clin Psychiatry. 2009 Oct;70(10):1379-84. doi: 10.4088/JCP.08m04593. Epub 2009 Jun 30. J Clin Psychiatry. 2009. PMID: 19573495
-
Hypometabolism as a therapeutic target in Alzheimer's disease.BMC Neurosci. 2008 Dec 3;9 Suppl 2(Suppl 2):S16. doi: 10.1186/1471-2202-9-S2-S16. BMC Neurosci. 2008. PMID: 19090989 Free PMC article. Review.
-
Role of Medium Chain Triglycerides (Axona®) in the Treatment of Mild to Moderate Alzheimer's Disease.Am J Alzheimers Dis Other Demen. 2014 Aug;29(5):409-14. doi: 10.1177/1533317513518650. Epub 2014 Jan 9. Am J Alzheimers Dis Other Demen. 2014. PMID: 24413538 Review.
Cited by 109 articles
-
APOE Alleles and Diet in Brain Aging and Alzheimer's Disease.Front Aging Neurosci. 2020 Jun 10;12:150. doi: 10.3389/fnagi.2020.00150. eCollection 2020. Front Aging Neurosci. 2020. PMID: 32587511 Free PMC article. Review.
-
Obesity and Diabetes Mediated Chronic Inflammation: A Potential Biomarker in Alzheimer's Disease.J Pers Med. 2020 May 22;10(2):42. doi: 10.3390/jpm10020042. J Pers Med. 2020. PMID: 32455946 Free PMC article. Review.
-
Evidence of the Role of Omega-3 Polyunsaturated Fatty Acids in Brain Glucose Metabolism.Nutrients. 2020 May 12;12(5):1382. doi: 10.3390/nu12051382. Nutrients. 2020. PMID: 32408634 Free PMC article. Review.
-
Evaluation of a ketogenic diet for improvement of neurological recovery in individuals with acute spinal cord injury: study protocol for a randomized controlled trial.Trials. 2020 May 4;21(1):372. doi: 10.1186/s13063-020-04273-7. Trials. 2020. PMID: 32366293 Free PMC article.
-
Are ketogenic diets promising for Alzheimer's disease? A translational review.Alzheimers Res Ther. 2020 Apr 14;12(1):42. doi: 10.1186/s13195-020-00615-4. Alzheimers Res Ther. 2020. PMID: 32290868 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
-
Full Text Sources
-
Other Literature Sources
-
Medical
-
Miscellaneous